Novedades

• Five Chinese companies join UN’s MPP for Covid-19 medicines
• South Korean companies to make generic Bridion and COVID-19 drugs
• Revlimid (lenalidomide) generics launch across Europe
• Cancer and diabetes generic treatments receive positive opinion from EMA’s CHMP

Investigación

• Re-evaluation of the use of generics, especially when treating conditions such as epilepsy
• La reutilización de medicamentos genéricos puede ahorrar tiempo y dinero
• Availability of medicines and the sustainable development of the national health system in Russia
• Generic etoricoxib is equivalent to the reference drug

General

• High drug bills? Turn to your pharmacist for help
• FDA Office of Generic Drugs publishes 2021 annual report
• Vacuna COVID-19 producida en América Latina
• Drug shortages hit Japan and Europe

Novedades

• Nuevos biosimilares de adalimumab se preparan para su lanzamiento en Canadá, EE.UU. y Europa
• FDA approves Amneal’s bevacizumab biosimilar
• Europe: positive opinion for Inpremzia and Truvelog Mix 30 and Stimufend authorized
• FDA approves Kashiv Biosciences’ filgrastim biosimilar

Investigación

• Innovent and Eli Lilly announce final results for sintilimab plus biosimilar bevacizumab injection
• Biosimilar adoption and prescribing in Japan: a physician opinion survey
• Totality of evidence supporting approval of Avsola in the treatment of IBD
• Survey results of biosimilars use among Spanish physicians and pharmacists

General

• HHS new study on biosimilar use and expanded trials will include older patients
• Needle-free delivery of biological drugs from Rani and Progenity
• British Columbia adds coverage for three new enoxaparin biosimilars
• Biocomparables aprobados en México

• Latin American Forum
• Fármacos complejos no biológicos
• Enfoque por país

• Directrices
• Políticas y legislación
• Informes

• Congresos
• Artículos patrocinados
• Enlaces patrocinados